Elan shopping spree in U.S. nets Dura Pharmaceuticals
Article Abstract:
Irish drug manufacturer Elan Corp. has agreed to purchase San Diego-based Dura Pharmaceuticals Inc. in a stock swap worth $1.8 billion (Euro2.1 billion). The acquisition would boost Elan into the respiratory drugs and antibiotics markets, and also double the size of the company's U.S. sales force.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
Asset sales & divestitures, Foreign operations, Ireland, Dura Pharmaceuticals Inc., Elan Corporation PLC, DURA, ELN
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Pfizer to sell incontinence drug to defuse competition concerns
Article Abstract:
Pfizer Inc. has reached a deal to sell its darifenacin incontinence drug to Novartis AG. The sale stems from antitrust issues related to Pfizer's pending merger with Pharmacia Corp. The drug deal is valued at $225 million (211.4 million euros).
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
Product information, Switzerland, Metabolic Agents NEC, Metabolic Agents, Company acquisition/merger, Novartis AG, Pfizer Inc., PNU, PFE, Pharmacia Corp., NVTSY, Darifenacin (Medication)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Pharmaceutical industry, Mergers, acquisitions and divestments, Drugs
Similar abstracts:
- Abstracts: SAirGroup to sell Swissotel to Raffles for 340 million euros. SAirGroup agrees to buy control of Sabena in share-swap deal
- Abstracts: Georgia-Pacific takeover plan may set off antitrust concerns. International Paper bids for rival
- Abstracts: Opel chief is set to announce blueprint to turn around firm. Chrysler will miss profit target for 2000
- Abstracts: Red Elecrica, Zeltia shares soar in anticipation of inclusion in index. TX may sell stake in utility
- Abstracts: Spanish government and banks pull the plug on KPN-Telefonica. KPN's sale of Cesky stake flounders
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.